Evidence map›Paper›PMID 16482387›Full record

ArticleMycopathologia2006

Molecular analysis and susceptibility profiling of Candida albicans isolates from immunocompromised patients in South India.

C P Girish Kumar, Ahmed Medhat Hanafy, Masakazu Katsu, Yuzuru Mikami, Thangam Menon

Abstract read
PubMed Publisher
In one paragraph

Article in Mycopathologia, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

C P Girish KumarDepartment of Microbiology, Dr. AL Mudaliar Post Graduate Institute of Basic Medical Sciences, University of Madras, Taramani, Chennai, TN, India.
Ahmed Medhat Hanafy
Masakazu Katsu
Yuzuru Mikami
Thangam Menon

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The genetic diversity and in vitro antifungal susceptibility profiles of 55 Candida albicans from immunocompromised patients were studied. PCR based analysis of the transposable intron in the 25S rDNA revealed 39 genotype A, 4 genotype B and 12 genotype C isolates. Serotype analysis categorized 52 isolates as serotype A and 3 as serotype B. All strains were susceptible to micafungin, 5-flucytosine and miconazole, whereas resistance against amphotericin B (3.6%), fluconazole (3.6%), itraconazole (7.3%) and voriconazole (5.5%) was observed. No association was seen between antifungal resistance and genotype/serotype status.

Indexed as

Immunocompromised HostAntifungal AgentsCandida albicansCandidiasisDNA, FungalGenetic VariationGenotypeHumansIndiaMicrobial Sensitivity TestsPolymerase Chain ReactionRNA, RibosomalSerotypingAntifungal AgentsDNA, FungalRNA, RibosomalRNA, ribosomal, 25S

Identifiers

PMID16482387

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.